Stratifying our cohort by invasiveness, i.e., into papillary non-invasive (pTa) and invasive tumors (pT1–pT4), FGFR3 overexpression (Tomlinson Score 3) was not associated with tumor progression in pTa bladder cancer (p > 0.05 for PFS) (Figure 3A). The gene discussed is FGFR3; the disease is urinary bladder carcinoma.